Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · February 13, 2022

DPP4 Inhibition Increases Serum Catecholamines During Sustained ACE Inhibitor Treatment



Additional Info

DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment
Hypertension 2022 Jan 20;[EPub Ahead of Print], JR Wilson, EM Garner, M Mashayekhi, SA Hubers, CE Ramirez Bustamante, SJ Kerman, H Nian, CA Shibao, NJ Brown

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading